Skip to Main Content

Paper Details

A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects.
3
2023
Memantine, Participants, Patients, breast cancer, early breast cancer, memantine, patients, stage I-III breast cancer
Author NameAffiliation
Lisa A CareyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Lisa A CareyUniversity of North Carolina at Chapel Hill
  • 1 - 2

Datasets

Release 1.2